Top 10 Companies in the 1,1‑Dimethyl guanidinium sulfate (CAS 2026‑46‑5) Market (2026): Market Leaders Driving Global Demand

MARKET INSIGHTS

Global 1,1‑Dimethyl guanidinium sulfate (CAS 1186‑46‑5) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 29.8 million in 2026 to USD 47.2 million by 2034, exhibiting a CAGR of 5.9% during the forecast period.

1,1‑Dimethyl guanidinium sulfate is an organic salt derived from dimethylguanidine and sulfuric acid, recognized for its high water solubility and chemical stability. The compound serves as a key intermediate and reagent across pharmaceutical synthesis, agrochemical formulations, and specialty chemical manufacturing. Its well‑defined ionic structure and guanidinium functionality make it particularly valuable in research applications and as a precursor in the synthesis of biologically active molecules.

The market is witnessing steady growth driven by expanding pharmaceutical R&D activities, increasing demand for high‑purity chemical intermediates, and rising utilization in life sciences research. Furthermore, growing investments in agrochemical innovation and the broader specialty chemicals sector continue to support demand. Key suppliers operating in this space include TCI Chemicals, Sigma‑Aldrich (Merck KGaA), and Alfa Aesar, each offering the compound across varying purity grades to serve diverse industrial and research end‑users.

1,1‑Dimethyl guanidinium sulfate (CAS 2026‑46‑5) Market – View in Detailed Research Report

Top 10 Companies in the 1,1‑Dimethyl guanidinium sulfate Market

1. Tokyo Chemical Industry Co., Ltd. (TCI)

   Headquarters: Tokyo, Japan
   Key Offering: Pharmaceutical‑grade and technical‑grade 1,1‑Dimethyl guanidinium sulfate

   TCI has built a reputation for delivering high‑purity intermediates to the pharmaceutical sector. Its manufacturing facilities are GMP‑certified, ensuring compliance with global regulatory standards. The company’s focus on process optimization has reduced production costs while maintaining stringent quality controls.

   Sustainability Initiatives:

   • Implementation of water‑recycling systems in synthesis lines
   • Adoption of renewable energy sources for facility operations
   • Carbon‑offset programs aligned with corporate sustainability goals

2. Merck KGaA (Sigma‑Aldrich)

   Headquarters: Darmstadt, Germany
   Key Offering: Research‑grade reagents with extensive analytical support

   Sigma‑Aldrich provides a broad catalogue of guanidinium salts, backed by comprehensive certificates of analysis. The company’s research division collaborates with academic laboratories to develop new synthetic routes, positioning it as a partner in discovery science.

   Sustainability Initiatives:

   • Investment in green chemistry research to replace hazardous reagents
   • Transparent reporting of environmental metrics in annual sustainability reports
   • Support for circular economy projects within the chemical industry

3. Fluorochem Ltd.

   Headquarters: London, United Kingdom
   Key Offering: High‑purity specialty chemicals for agro‑ and pharmaceutical applications

   Fluorochem’s niche focus on specialty intermediates has allowed it to capture a dedicated client base in the UK and EU. The company emphasizes rigorous quality assurance and offers customized synthesis services.

   Sustainability Initiatives:

   • Use of biodegradable solvents in laboratory processes
   • Participation in EU Green Deal initiatives
   • Reduction of hazardous waste through process redesign

4. Jinan Great Chemical Industry Co., Ltd.

   Headquarters: Jinan, China
   Key Offering: Cost‑effective technical‑grade guanidinium sulfate for industrial synthesis

   Jinan Great Chemical leverages China’s robust supply chain for raw materials, enabling competitive pricing. The firm has recently upgraded its production lines to meet GMP requirements for export markets.

   Sustainability Initiatives:

   • Implementation of energy‑efficient heating systems
   • Compliance with China’s 2025 environmental regulations
   • Partnerships with local universities for sustainable chemistry research

5. Hangzhou Dayangchem Co., Ltd.

   Headquarters: Hangzhou, China
   Key Offering: Flexible batch sizes for custom synthesis projects

   Hangzhou Dayangchem serves a diverse clientele, including contract manufacturers and research institutes. Its flexible production model supports small‑batch, high‑purity demands.

   Sustainability Initiatives:

   • Adoption of waste‑minimization protocols
   • Use of renewable electricity in production facilities
   • Engagement in local community environmental programs

6. Anji Biochemical Co., Ltd.

   Headquarters: Anji, China
   Key Offering: Research‑grade reagents with rapid turnaround times

   Anji Biochemical has developed a rapid synthesis platform that reduces lead times for research laboratories. The company emphasizes high‑quality analytical support.

   Sustainability Initiatives:

   • Implementation of closed‑loop water systems
   • Reduction of volatile organic compound emissions
   • Collaboration with academic institutions on green chemistry projects

7. Zhengzhou Alfa Chemical Co., Ltd.

   Headquarters: Zhengzhou, China
   Key Offering: High‑purity intermediates for pharmaceutical and agrochemical synthesis

   Alfa Chemical focuses on maintaining stringent purity thresholds. The firm’s quality management system aligns with ISO 9001 and ISO 14001 standards.

   Sustainability Initiatives:

   • Use of low‑energy synthesis processes
   • Compliance with ISO 14001 environmental management
   • Participation in regional sustainability forums

8. Combi‑Blocks, Inc.

   Headquarters: St. Louis, United States
   Key Offering: Custom‑synthesis services for niche guanidinium intermediates

   Combi‑Blocks specializes in bespoke synthesis, catering to small‑batch, high‑value projects. The company’s laboratories are equipped for rapid scale‑up.

   Sustainability Initiatives:

   • Adoption of green chemistry principles in custom synthesis
   • Use of recyclable packaging for shipped reagents
   • Carbon‑neutral shipping options for domestic customers

9. Haihang Industry Co., Ltd.

   Headquarters: Haihang, China
   Key Offering: Technical‑grade intermediates for large‑scale production

   Haihang focuses on high‑volume manufacturing, providing reliable supply to integrated pharmaceutical manufacturers. The firm has recently upgraded its facilities to meet international safety standards.

   Sustainability Initiatives:

   • Implementation of waste‑to‑energy conversion systems
   • Adherence to China’s national environmental targets
   • Investment in employee environmental training programs

10. Triveni Chemicals

    Headquarters: Noida, India
    Key Offering: Technical and research‑grade guanidinium sulfate with flexible packaging

    Triveni serves a growing Indian pharmaceutical market, offering competitive pricing and quick delivery. The company has established a dedicated quality assurance team.

    Sustainability Initiatives:

    • Use of renewable energy in production plants
    • Implementation of water‑recycling protocols
    • Support for local environmental conservation projects

1,1‑Dimethyl guanidinium sulfate (CAS 2026‑46‑5) Market – View in Detailed Research Report

1,1‑Dimethyl guanidinium sulfate (CAS 2026‑46‑5) Market – View in Detailed Research Report

Market Outlook

The next decade will see continued demand for 1,1‑Dimethyl guanidinium sulfate as a critical building block in the synthesis of antidiabetic and other therapeutic agents. The expanding portfolio of biguanide‑based drugs, coupled with ongoing research into guanidine‑containing bioactive molecules, will sustain the need for high‑purity intermediates. The rise of contract development and manufacturing organizations (CDMOs) will further reinforce the market’s reliance on specialty suppliers capable of delivering consistent quality and regulatory documentation.

Future Trends

Emerging green chemistry initiatives are reshaping the synthesis landscape. Companies that can demonstrate low‑to‑zero hazardous waste generation and reduced reliance on heavy‑metal catalysts will gain a competitive edge. Additionally, the growing focus on precision medicine and orphan drug development is creating opportunities for small‑batch, high‑value synthesis of niche intermediates. Regulatory frameworks that tighten elemental impurity limits will also drive investment in advanced analytical capabilities, positioning suppliers that already possess robust quality systems as preferred partners.